"Radiation Oncology at Oneida provides patients with a treatment option closer to home, and an easy connection to the main Upstate Cancer Center site in Syracuse"

During the past decade, Upstate Cancer Center at Oneida conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Upstate Cancer Center at Oneida" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "NRG Oncology" with 1 trials sponsored and "RTOG Foundation, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Upstate Cancer Center at Oneida" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Upstate Cancer Center at Oneida" are "Stage IIIB Lung Cancer AJCC v8" (5 trials), "Invasive Breast Carcinoma" (4 trials), "Anatomic Stage II Breast Cancer AJCC v8" (3 trials), "Prognostic Stage II Breast Cancer AJCC v8" (3 trials) and "Stage IIIC Lung Cancer AJCC v8" (3 trials). Many other conditions were trialed in "Upstate Cancer Center at Oneida" in a lesser frequency.

Most popular intervention types in "Upstate Cancer Center at Oneida" are "Drug" (19 trials), "Other" (16 trials), "Biological" (14 trials), "Procedure" (10 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (9 trials), "Questionnaire Administration" (8 trials), "Biospecimen Collection" (6 trials), "Pembrolizumab" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Upstate Cancer Center at Oneida" are 21 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Upstate Cancer Center at Oneida". undefined are not yet recruiting, 16 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Upstate Cancer Center at Oneida, 4 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Upstate Cancer Center at Oneida, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".